Session Chair Profile

MBA, President and CEO, Health Catalysts / Executive Chair, GenePeeks

Aspinall is CEO of Health Catalysts, a healthcare investment firm. Aspinall is also Executive Chair of GenePeeks, a computational genomics company to identify the risk of passing on monogenic disease to progeny (pre-conception) through data mining the parental genomes. Aspinall is former President and CEO of Ventana Medical Systems, leader in cancer diagnostics. Mara previously spent 12 years as President of Genzyme Genetics and Genzyme Pharmaceuticals. Aspinall is on the Board of Safeguard Scientifics, Abcam plc, BCBS AZ and Castle Biosciences. Aspinall is passionate about education on diagnostics, genomics and personalized medicine. To that end, Aspinall co-founded the School of Biomedical Diagnostics at Arizona State University, the first school dedicated to Diagnostics as an independent discipline. The School awarded their first Master degrees in 2015. Aspinall is a frequent industry speaker. She was named Arizona Biosciences Leader of the Year and one of “100 Most Inspiring People in Life Sciences” by PharmaVOICE magazine.

Session Abstract – PMWC 2017 Silicon Valley

Session Synopsis: Personalized Medicine investment is still in its adolescence in both therapeutics and diagnostics. There have been a few huge wins but also unexpected disappointments. The panel will discuss where PM goes next and the hallmarks of an early success or failure.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.